Biopharma | April 14, 2026
Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
The license is valid for five years, effective from April 9, 2026
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Subscribe To Our Newsletter & Stay Updated
